Article
Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance
26 Aug 2019
Abstract excerpt
Only a subset of cancer patients respond to T-cell checkpoint inhibitors, highlighting the need for alternative immunotherapeutics. We performed CRISPR-Cas9 screens in a leukemia cell line to identify perturbations that enhance natural killer effector functions. Our screens defined critical components of the tumor-immune synapse and highlighted the importance of cancer cell interferon-γ signaling in modulating NK...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
